Diabetic Retinopathy Market Size, Status and Forecast 2019-2025
Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabetic retinopathy is broadly classified into non-proliferative diabetic retinopathy and proliferative retinopathy. Treatment for diabetic retinopathy depends on the stage of the disease and is directed toward slowing down or stopping the progression of the disease.
Laser surgery, injection of corticosteroids or anti-VEGF drugs into the eye, and vitrectomy are some of the available treatments. One feature of diabetic retinopathy is diabetic macular edema. This is a serious medical condition involving leakage of fluid from the minute, delicate, and previously injured blood vessels located at the back of the eye, which then collects in the macula. This results in inflammation of tissue and blurry vision.
In 2018, the global Diabetic Retinopathy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Diabetic Retinopathy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Diabetic Retinopathy development in United States, Europe and China.
The key players covered in this study
- F. Hoffmann-La Roche
- Regeneron Pharmaceuticals
- Alimera Sciences
- Ampio Pharmaceuticals
- Antisense Therapeutics
Report Sample includes:
– Table of Contents
– List of Tables & Figures
– Research Methodology
More Deatiled Market Analysis of Diabetic Retinopathy Industry @ Free PDF Sample copy
Market segment by Type, the product can be split into
- Laser surgery
- Injection of corticosteroids
- Anti-VEGF drugs into the eye
Market segment by Application, split into
- Clinics and laboratories
Market segment by Regions/Countries, this report covers
- United States
- Southeast Asia
- Central & South America
The study objectives of this report are:
- To analyze global Diabetic Retinopathy status, future forecast, growth opportunity, key market and key players.
- To present the Diabetic Retinopathy development in United States, Europe and China.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Diabetic Retinopathy are as follows:
- History Year: 2014-2018
- Base Year: 2018
- Estimated Year: 2019
- Forecast Year 2019 to 2025